The multiple roles of life stress in metabolic disorders

M Kivimäki, A Bartolomucci, I Kawachi - Nature Reviews Endocrinology, 2023 - nature.com
The activation of stress-related neuroendocrine systems helps to maintain homeostasis, but
excessive stress can damage body functions. We review current evidence from basic …

Social determinants of health and cardiovascular disease: current state and future directions towards healthcare equity

MH Jilani, Z Javed, T Yahya, J Valero-Elizondo… - Current atherosclerosis …, 2021 - Springer
Abstract Purpose of Review We sought to examine the role of social and environmental
conditions that determine an individual's behaviors and risk of disease—collectively known …

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association …

Writing Committee Members, SS Virani… - Journal of the American …, 2023 - jacc.org
Abstract Aim The “2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management
of Patients With Chronic Coronary Disease” provides an update to and consolidates new …

Bempedoic acid: for whom and when

M Ruscica, CR Sirtori, S Carugo, M Banach… - Current Atherosclerosis …, 2022 - Springer
Abstract Purpose of Review The aim of creating an orally active non-statin cholesterol-
lowering drug was achieved with bempedoic acid, a small linear molecule providing both a …

Medication adherence in cardiovascular medicine

ST Simon, V Kini, AE Levy, PM Ho - Bmj, 2021 - bmj.com
Cardiovascular disease is the leading cause of death globally. While pharmacological
advancements have improved the morbidity and mortality associated with cardiovascular …

[HTML][HTML] Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific …

A Khera, SJ Baum, TJ Gluckman, M Gulati… - American journal of …, 2020 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) pandemic has consumed our
healthcare system, with immediate resource focus on the management of high numbers of …

Financial toxicity in atherosclerotic cardiovascular disease in the United States: current state and future directions

R Khera, J Valero-Elizondo, K Nasir - Journal of the American …, 2020 - Am Heart Assoc
Atherosclerotic cardiovascular disease (ASCVD) has posed an increasing burden on
Americans and the United States healthcare system for decades. In addition, ASCVD has …

Association of socioeconomic disadvantage with long-term mortality after myocardial infarction: the Mass General Brigham YOUNG-MI Registry

AN Berman, DW Biery, C Ginder, A Singh… - JAMA …, 2021 - jamanetwork.com
Importance Socioeconomic disadvantage is associated with poor health outcomes.
However, whether socioeconomic factors are associated with post–myocardial infarction …

Added therapeutic benefit of top-selling brand-name drugs in Medicare

AC Egilman, BN Rome, AS Kesselheim - JAMA, 2023 - jamanetwork.com
Importance The Inflation Reduction Act of 2022 authorizes Medicare to negotiate prices of
top-selling drugs based on several factors, including therapeutic benefit compared with …

Financial burden, distress, and toxicity in cardiovascular disease

SD Slavin, R Khera, SY Zafar, K Nasir… - American heart journal, 2021 - Elsevier
Highlights•Cardiovascular disease (CVD) is a major source of financial burden and financial
distress, which can cause psychological distress, cost-related care non-adherence or care …